Protocol: F-AV-45-A17 PET scan using an investigational radioactive drug to help determine the likely cause of cognitive decline.

A short study involving one clinic visit and one PET scan, which uses Florbetapir┬« as an imaging agent to help determine whether or not Alzheimer’s Disease is the cause of cognitive decline.

  • Male/Female age 50 or older
  • Must have had symptoms of mild cognitive decline for at least 6 months
  • Initial evaluation by a physician must have occurred no more than 18 months ago